X-Message-Number: 27928 From: "Hare, Tim R" <> Subject: RE: Brain aging interventions [Posit Science White Paper] Date: Wed, 10 May 2006 15:22:16 -0400 This message is in MIME format. Since your mail reader does not understand this format, some or all of this message may not be legible. ------_=_NextPart_001_01C67467.0C960E0A From the discussion: "We have conducted preliminary studies showing that an intensive brain plasticity-based training program can significantly enhance neurocognitive function in healthy older adults, and we are now planning large, randomized, controlled trials to rigorously determine the types and magnitude of gains that can be expected." Exciting, if these plans are eventually realized. To the degree that the above is successful, one can go on to contemplate the impact of such training combined with proper age-pertinent conditional micronutrients, dietary adjuvants, and pharmacologic support. Best, T- -----Original Message----- From: Hare, Tim R Sent: Wednesday, May 10, 2006 10:07 AM To: '' Subject: Brain aging interventions [Posit Science White Paper] All, Attached is the white paper I requested from Posit Science. Enjoy. T- Timothy R. Hare Automated Biotechnology (952) Bld NW-2, 503 Louise Lane, North Wales, PA 19454 Merck E-mail: <mailto: <mailto:> > Voice: (267) 305-3235 Mobile (267) 984-7136 FAX: (267) 305-0182 -----Original Message----- From: Mark Johnson [mailto:] Sent: Tuesday, May 09, 2006 8:59 PM To: Hare, Tim R Subject: Posit Science White Paper Dear Mr. Hare, I trust that this message finds you well. Previously you and I had communicated about a white paper that Posit Science would make available to the public, and I wrote you that I would attempt to secure you an advance copy of this document. You will find this document attached to this email, but please note that the document is a draft, not a final document, and it may yet sustain changes for style and grammar. As previously mentioned, the document contains more than 200 sources from which you may begin your personal research (on www.pubmed.gov <http://www.pubmed.gov/> , for example) to as you stated see where the science we employ at Posit Science fits in with other studies and available scientific literature. I hope you will enjoy reading the document. Should you have any questions please feel free to contact me. Best regards, Mark Johnson Mark Johnson Customer Delight Specialist Posit Science Corporation 225 Bush Street, 7th Floor San Francisco, CA 94104 Direct: 415 394 2570 Main: 415 394 3100 Fax: 415 986 2829 <mailto:> www.PositScience.com <http://www.positscience.com/> Notice: This e-mail message, together with any attachments, contains information of Merck & Co., Inc. (One Merck Drive, Whitehouse Station, New Jersey, USA 08889), and/or its affiliates (which may be known outside the United States as Merck Frosst, Merck Sharp & Dohme or MSD and in Japan, as Banyu) that may be confidential, proprietary copyrighted and/or legally privileged. It is intended solely for the use of the individual or entity named on this message. If you are not the intended recipient, and have received this message in error, please notify us immediately by reply e-mail and then delete it from your system. ------_=_NextPart_001_01C67467.0C960E0A Content-Type: text/html [ AUTOMATICALLY SKIPPING HTML ENCODING! ] Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=27928